Entering a new phase of immunogenetics in the idiopathic inflammatory myopathies

    Research output: Contribution to journalArticlepeer-review


    PURPOSE OF REVIEW: To review the progress that has been made in understanding the genetics of the idiopathic inflammatory myopathies (IIMs) in the past 2 years, with particular focus on polymyositis, dermatomyositis and inclusion body myositis. RECENT FINDINGS: Candidate gene studies in the Japanese population have implicated signal transducer and activator of transcription 4 as a risk locus for IIM, and HLA-DRB1 as a risk locus for anti-melanoma differentiation-associated gene 5-positive dermatomyositis. Evidence for gene-environment interactions has been found between HLA-DRB1*03 and smoking as a risk factor for the development of anti-histidyl tRNA synthetase antibodies, and HLA-DRB1*11:01 and statins for the development of anti-hydroxymethyl glutaryl-coenzyme A reductase-positive statin-induced myopathy. The HLA-DRB1*03:01/*01:01 genotype confers the highest disease risk in inclusion body myositis. A recent genome-wide association study has been performed in dermatomyositis. The most significant signals were in the major histocompatibility complex region, with other loci suggesting evidence of genetic overlap with different autoimmune diseases. SUMMARY: Recent association and gene-environment interaction studies have increased our knowledge of genetic risk factors for the IIMs. Ongoing international collaborations will facilitate larger and more meaningful genetic studies revealing much about the genetic architecture of these complex diseases. © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins.
    Original languageEnglish
    Pages (from-to)735-741
    Number of pages6
    JournalCurrent Opinion in Rheumatology
    Issue number6
    Publication statusPublished - Nov 2013


    • Candidate gene
    • Gene-environment interaction
    • Genetics
    • Human leukocyte antigen
    • Myositis


    Dive into the research topics of 'Entering a new phase of immunogenetics in the idiopathic inflammatory myopathies'. Together they form a unique fingerprint.

    Cite this